Effect of 12-month intervention with lipid-based nutrient supplements on physical activity of 18-month-old Malawian

A Pulakka1, U Ashorn1, Y B Cheung2

  • 1University of Tampere School of Medicine, Department for International Health, Tampere, Finland.

Insights

Dietary lipid-based nutrient supplements (LNSs) did not significantly impact physical activity levels in Malawian toddlers. This 12-month supplementation study found no measurable increase in activity for children aged 6-18 months.

Area of Science:

  • Pediatric Nutrition
  • Child Development
  • Micronutrient Supplementation

Background:

  • Childhood physical activity is crucial for healthy development.
  • Lipid-based nutrient supplements (LNSs) are used to address micronutrient deficiencies in young children.
  • The impact of LNSs on physical activity in toddlers requires further investigation.

Purpose of the Study:

  • To evaluate the effect of daily LNS supplementation on the physical activity of Malawian toddlers.
  • To compare different doses and types of LNSs (milk-based vs. non-milk-based) on physical activity outcomes.

Main Methods:

  • A randomized, controlled, outcome-assessor blinded trial involving 1932 children aged 6 months in Malawi.
  • Children received daily LNS interventions (10-40g, milk or non-milk based) or no intervention from 6-18 months.
  • Physical activity was measured at 18 months using accelerometers (ActiGraph GT3X+) over one week.

Main Results:

  • A total of 1053 children provided sufficient accelerometer data for analysis.
  • No statistically significant differences in mean vector magnitude accelerometer counts were observed across LNS groups compared to the control group.
  • Specific differences ranged from -11 to 21 counts/15s, with P-values indicating no significant effect.

Conclusions:

  • Daily LNS supplementation (10-40g) for 12 months did not enhance the physical activity of Malawian toddlers.
  • The findings suggest that LNSs, in the studied dosages, do not influence accelerometer-measured physical activity in this population.
  • Further research may explore other potential benefits or different intervention strategies.
Abstract

Related Concept Videos

Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.8K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
437
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K